Resveratrol dual efficacy in high-altitude hypoxia and NAFLD: inhibits ferroptosis by modulating key proteins, including HIF-1α, ACSL4, and TfR1
Phytomedicine · 2026
DOI: 10.1016/j.phymed.2026.157992 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Minghui Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Lanzhou University, Lanzhou 730050, China; Department of Pharmacy, The 940th Hospital of Joint Logistics Support Force of Chi…. Hauptthemen laut MEDLINE: Ferroptosis, Resveratrol, Non-alcoholic Fatty Liver Disease, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Gansu Provincial Natural Science Foundation.
Abstract (Originalsprache)
BACKGROUND: The effects of persistent hypoxic conditions in high-altitude regions on metabolic disorders remain poorly understood and in-depth investigation into its underlying molecular mechanisms is notably insufficient. As a metabolism-associated liver disease, the pathogenesis of non-alcoholic fatty liver disease (NAFLD) under hypoxic conditions urgently requires clarification. Previous studies have demonstrated that resveratrol (Rsv) possesses significant anti-inflammatory, antioxidant, and lipid metabolism-modulating properties, and it can act as an inhibitor of ferroptosis. Yet its precise therapeutic efficacy and mechanism in hypoxic NAFLD remain to be further explored. OBJECTIVE: This study aims to explore the potential mechanism by which Rsv improves the deterioration of NAFLD under hypoxia exposure. METHODS: Herein, we performed concurrent interventions in both in vivo and in vitro models of NAFLD, comprehensively detecting biochemical indicators (inflammatory factors, oxidative stress markers, liver function), liver histopathological changes, and nucleic acid levels to assess the effects of Rsv. By introducing ferroptosis modulators, we measured core ferroptosis parameters (mitochondrial ultrastructure, Fe²⁺, 4-HNE, LPO levels, and key protein expressions) to define disease progression patterns. By HIF-1α silencing was employed to verify its regulatory roles in ferroptosis-related factors and NAFLD pathogenesis. Co-Immunoprecipitation assays and immunofluorescence co-localization were used to explore protein interactions among ACSL4, TfR1, and HIF-1α. CONCLUSION: Our results demonstrated that high-altitude hypoxia exacerbates NAFLD via inducing ferroptosis; HIF-1α upregulates the expression of key ferroptosis mediators (ACSL4, TfR1), and HIF-1α silencing attenuates ferroptosis. Rsv exerts therapeutic effects against hypoxia-related NAFLD by targeting the HIF-1α-mediated ferroptosis pathway. This study elucidates the pivotal role of HIF-1α-dependent ferroptosis in hypoxia-aggravated NAFLD, identifies the therapeutic targets and mechanisms of Rsv, and provides novel theoretical foundations and potential intervention strategies for clinical management of hypoxia-related NAFLD in high-altitude areas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Lanzhou University, Lanzhou 730050, China; Department of Pharmacy, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou 730050, China.
- Department of Pharmacy, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou 730050, China.
- Department of Pharmacy, Lanzhou University, Lanzhou 730050, China; Department of Pharmacy, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou 730050, China. Electronic addre…
Förderung
- National Natural Science Foundation of China
- Gansu Provincial Natural Science Foundation
Zitieren
APA
Zhao, M., Mu, H., Ji, Q., Song, J., Zheng, F., Liu, T., Li, W., & Wang, R. (2026). Resveratrol dual efficacy in high-altitude hypoxia and NAFLD: inhibits ferroptosis by modulating key proteins, including HIF-1α, ACSL4, and TfR1. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.157992
Vancouver
Zhao M, Mu H, Ji Q, Song J, Zheng F, Liu T, et al. Resveratrol dual efficacy in high-altitude hypoxia and NAFLD: inhibits ferroptosis by modulating key proteins, including HIF-1α, ACSL4, and TfR1. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.157992
BibTeX
@article{Zhao2026,
author = {Zhao, Minghui and Mu, Hongfang and Ji, Qian and Song, Jiale and Zheng, Fuyixuan and Liu, Tianlong and Li, Wenbin and Wang, Rong},
title = {Resveratrol dual efficacy in high-altitude hypoxia and NAFLD: inhibits ferroptosis by modulating key proteins, including HIF-1α, ACSL4, and TfR1},
journal = {Phytomedicine},
year = {2026},
doi = {10.1016/j.phymed.2026.157992}
}
EUVIMED